Filgrastim

CHEMBL1201567 Phase 4 अनुमोदित Protein
Half-Life
Bioavailability
Protein Binding
Molecular Weight
g/mol
LogP
Phase
4

This medication is a laboratory-made version of a natural protein called granulocyte colony-stimulating factor, which stimulates the bone marrow to produce more white blood cells. It is used to reduce the risk of serious infection in patients whose immune systems have been weakened by chemotherapy or other conditions.

चिकित्सीय क्षेत्र

Pharmacokinetics (PK)

Pharmacodynamics (PD)

HBD / HBA

- / -

No targets recorded

Target interaction data is not yet available for this drug.

No interactions recorded

Drug interaction data is not yet available for this compound.

No side effects recorded

Side effect data is not yet available for this drug.

अक्सर पूछे जाने वाले प्रश्न

This medication is a laboratory-made version of a natural protein called granulocyte colony-stimulating factor, which stimulates the bone marrow to produce more white blood cells. It is used to reduce the risk of serious infection in patients whose immune systems have been weakened by chemotherapy or other conditions.

Yes, Filgrastim is an approved drug. It has reached clinical phase 4. It is classified as a Protein.

{# References & Data Sources section for drug detail pages. Renders standard pharmacological database links plus the drug's data_sources field. #}

References & Data Sources

  • ChEMBL — European Bioinformatics Institute (EBI). CHEMBL1201567. Open-access bioactivity database.

Data aggregated from publicly available pharmacological databases. Last updated 2026-02-27.

चिकित्सा अस्वीकरण

This content is for educational and informational purposes only. It is not a substitute for professional medical advice, diagnosis, or treatment. Always consult a qualified healthcare provider before making medication decisions.

Data sources: ChEMBL, PubChem, DailyMed.